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Iinical 
genal Involvement in Type 2 Diabetes Mellitus: A Clinicopathologic 
Study of the Henry Ford Hospital Experience 
Francis Dumler, MD,* Vijay Kumar, MD,^  Raymond N. Romanski, MD,^  
Pedro Cortes, MD,* and Nathan W. Levin, MD* 
To better understand renal dysfunction in type 2 diabetes mellitus, we studied the clinical and autopsy 
findings in comparable cohorts of 108 diabetic and 77 nondiabetic patients. In the diabetic group, no 
differences were noted between black and white patients in blood glucose concentrations, mean blood 
pressure, or the prevalence of diabetic glomerulosclerosis. However, the prevalence of renal 
insufficiency was significantly greater (P = 0.002) in black diabetics (58%) than in white diabetics 
(35%). black controls (28%), and white controls (20%). Logistic regression analysis demonstrated a 
significant association of renal insufficiency with diabetes (P = 0.006) and race (P = 0.032). butnot 
with mean blood pressure, age, or sex. An additional nonspecific glomerular lesion commonly found 
was global sclerosis. The occurrence of this lesion was significantly greater (P = O.OOI) in black 
diabetics (42% ± 5%) than in white diabetics (26% ± 5%), black controls (19% ± 4%), and white 
controls (21% ± 4%), and was highly correlated (P = O.OOI) to serum creatinine concentrations. In 
patients with serum creatinine concentrations lower than 1.6 mg/dL, kidney weight was significantly 
greater (P = 0.03) in diabetics with diabetic glomerulosclerosis (405 ± 32 g) as compared to those 
without it (300 ± 25 g) or to control patients (329 ± 13 g). This study demonstrates that the overall 
prevalence of diabetic glomerulosclerosis in this group of type 2 diabetics is 45%, and that renal 
enlargement is present in these patients prior to the development of significant renal insufficiency. In 
addition, renal insufficiency and end-stage renal failure are more common in black than in white 
diabetics. (Henry FordHosp MedJ 1987:35:221-5) 
R enal disease in type 1 (insulin-dependent) diabetes mellitus is well characterized and has been the subject of intense 
study (1-9). That clinical renal disease may differ in type 1 and 
type 2 (noninsulin-dependent) diabetes is suggested by a tenfold 
difference in the prevalence of diabetic renal disease as the cause 
of death in patients younger (20%) and older (2%) than 40 years 
of age. Although abnormal proteinuria may occur in 50% of pa-
tients with type 2 diabetes, the glomemlar filtration rate does not 
decrease progressively in most of these patients (10). While the 
vast majority of patients with type I diabetes mellitus who 
develop renal insufficiency have diabetic nephropathy (8), the 
extent to which diabetic nephropathy is responsible for renal in-
sufficiency in type 2 diabetics is not well defined. Because the 
relationship between renal insufficiency and diabetic nephrop-
athy requires histological confirmation, a retrospective autopsy 
study of 108 consecutive cases of type 2 diabetes mellitus was 
undertaken to address this issue. In addition, comparisons were 
made between blacks and whites in view of apparent racial dif-
ferences in the prevalence of end-stage renal failure from vari-
ous causes (11). 
Methods 
Patient population 
The Medical Records Department at Henry Ford Hospital 
identified in its computerized index 650 patients who were older 
than age 50 at death and whose complete medical and autopsy 
records were available for study. Of these 650 patients, 145 had 
been classified by their primary physician as having diabetes 
mellitus. The diagnosis of type 2 diabetes was retrospectively 
confirmed, and patients were included in the study oitiy if the 
following criteria were documented: 1) a negative history of dia-
betic ketoacidosis; 2) age at onset of diabetes of 40 years or 
older; and 3) body weight not less than 95% of the calculated 
ideal body weight based on sex, age, and height. A total of 108 
patients with type 2 diabetes as defined by these criteria were 
entered in the study. The remaining 505 nondiabetic patients 
were entered into the control group only if 1) plasma glucose 
concentrations were consistently lower than 180 mg/dL re-
gardless of time or circumstances, and 2) body weight was at 
least 95% of the calculated ideal body weight. A total of 77 pa-
tients fulfilled these criteria. 
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Table 1 
Clinical Characteristics ofthe Patient Population Studied 
DIABETICS CONTROLS 
Black White Black White 
Number of patients 49 59 37 40 
Age (years) 67 ± 2 68 ± 2 62 ± 2* 69 ± 2 
Males (%) 69 56 51 40 
Body weight (kg) 7 1 + 4 72 ± 3 72 ± 3 76 ± 2 
Mean blood pressure 
(mm Hg) 107 ± 2t 106 ± 2t 98 ± 4 101 ± 2 
Semm creatinine 
(mg/dL) 5.5 ± 0.8t 3.0 ± 0.05 3.3 ± 0. i 2.1 ± 0.6 
Duration of diabetes 
(years) 14 ± 1 13 ± 1 
— — 
Patients on insulin (%) 44 55 
— — 
*P = 0.03 when compared to the other groups. 
tP = 0.02 when compared to controls. 
tP = 0.02 when compared to the other groups. 
Clinicopathologic evaluation 
The following information was recorded for each patient: 
duration of diabetes, mode of diabetes therapy, mean blood 
pressure, blood glucose, degree of proteinuria, and semm creat-
inine concentrations at diagnosis and during the last admission. 
Blood pressure and blood glucose measurements during the last 
hospital admission were reviewed, and mean values utilized for 
analysis. Renal insufficiency was arbitrarily defined as a semm 
creatinine concentration consistently greater than 2 mg/dL, and 
end-stage renal failure as a seram creatinine concentration con-
sistentiy greater than 8 mg/dL or by the use of maintenance di-
alysis procedures. To ensure that renal function was documented 
during a representative steady state, if sudden changes in renal 
function occurred, the stable serum creatinine concentration 
preceding the acute event was used for analysis. Cardiac weight 
and left ventricular thickness measurements were recorded. 
All renal histological material was analyzed in a blind man-
ner by an independent observer who had no knowledge of the 
clinical or autopsy findings. Autopsy material for light micro-
scopic studies was considered adequate for reexamination in 134 
patients because postmortem alterations did not interfere with 
the evaluation of the following: 1) presence and degree of global 
glomerular sclerosis, 2) presence and degree of hyaline arte-
riosclerosis and intimal thickness of interlobular and arcuate 
arteries, and 3) presence of diabetic glomerulosclerosis. All 
glomemli in each kidney section were examined while avoiding 
areas of infarction. Global glomeralar sclerosis was defined as 
a rounded, solid scar replacing the entire glomerular tuft. 
Bowman's space, and blending with or obscuring Bowman's 
capsule. The degree of diabetic glomeralosclerosis and of arte-
riosclerosis was graded by using a 0 to 4 -F scale at the end of 
each slide examination. Diabetic glomerulosclerosis lesions 
were further classified as diffuse or nodular. 
Data management and statistical analysis 
Identification of all patients eligible for the study was con-
ducted by the Medical Records Department without prior 
knowledge of the presence or absence of diabetes. All statistical 
analyses were carried out with the Statistical Analysis System 
(12). Results are expressed as mean ± SEM or in frequency dis-
tributions. Comparison of means was carried out by analysis of 
variance followed by Duncan's multiple-range test. Frequency 
distributions were compared by analysis. The effects of risk 
factors for the development of renal insufficiency were analyzed 
by logistic regression. 
Results 
The characteristics of the patient populations are shown in 
Table 1. No differences were noted in age, duration of diabetes, 
or in the prevalence of insulin therapy between black and white 
diabetics (Table 1). There were no differences in sex distribution 
or body weight between groups. Body mass index was also sim-
ilar in all groups (39 ± 1, 39 ± 1, 39 ± 1, and 40 ± 1 kg/m^ in 
black diabetic, white diabetic, black control, and white control 
patients, respectively). Black control patients had a lower mean 
age (P = 0.03) than the other groups. Mean blood pressures 
were significantly higher (P = 0.02) in diabetic than in con-
trol patients, but blood pressure differences were not observed 
between races in diabetic or control patients (Table 1). No dif-
ferences in cardiac weights were noted between groups: black 
diabetics (485 ± 30 g), white diabetics (488 ± 11 g), black con-
trols (508 ± 24 g), and white controls (498 ± 22 g). Left ven-
tricular thickness was greater (P = 0.005) in white controls 
(1.69 ± 0.06 cm) than in black controls (1.59 ± 0.06 cm), 
white diabetics (1.41 ± 0.09 cm), or black diabetics (1.43 ± 
0. 10 cm). 
Routine urinalysis was negative for protein in 47% of control 
and 16% of diabetic patients (P = 0.001). A qualitative urinary 
protein excretion greater than 300 mg/dL was found in three 
(4%) control patients and in ten (3%) diabetic patients without 
diabetic nephropathy. Seram creatinine concentrations were sig-
nificantiy higher (P = 0.02) in black diabetic patients than in 
white diabetic or control patients (Table 1). The prevalence of 
renal insufficiency was significantly greater (P = 0.002) i " 
black diabetics (58%) as compared to white diabetics (35%)' 
black controls (28%), or white controls (20%), as shown in 
1. Similarly, the prevalence of end-stage renal disease was stg' 
nificantiy greater (P = 0.05) in black diabetics (27%) than i " 
white diabetics (10%), black controls (14%), and white controls 
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Table 2 
Prevalence (%) of Histological Diabetic Renal Disease 
DIABETICS CONTROLS 
Black White Black White 
Number of patients 35 29 30 40 
Diabetic glomeralosclerosis 45 40 
— — 
Grade 3 to 4 -1- arteriosclerosis 38 24 12 19 
Percent of glomemli with 
global sclerosis 42 ± 5* 26 ± 5 19 ± 4 21 ± 4 
*P = 0.001 when compared to the other groups. 
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%) (Fig 1). Only a weak correlation was found between mean 
blood pressure and serum creatinine concentrations in black 
(R = 0.246) and white (R = 0.132) patients. 
The prevalence of diabetic glomeralosclerosis was similar in 
black and white diabetic patients (Table 2), and the prevalence of 
renal insufficiency was 66% in patients with diabetic 
glomeralosclerosis and 36% in patients without it (x^ = 4.95; 
p = NS). No differences were noted in blood glucose concen-
trations between black (277 ± 22 mg/dL) and white (269 ± 
20 mg/dL) diabetic patients or between patients with and with-
out diabetic glomeralosclerosis (265 ± 25 mg/dL and 282 ± 
18 mg/dL, respectively). 
Grade 3 and 4 -F diabetic glomeralosclerosis were similarly 
present in black and white diabetics. Although the prevalence of 
grade 3 to 4 -I- lobular and arcuate arteriosclerosis was greater in 
black diabetics than in any other group, the differences were not 
statistically significant. However, the occurrence of global 
glomerular sclerosis was significantly greater (P = 0.001) in 
black diabetics than in white diabetics, black controls, or white 
controls (Table 2). A significant correlation was found between 
the degree of global sclerosis and the logarithm of serum 
creatinine concentrations in all patient groups (R = 0.729; P = 
0.001). 
No differences in kidney weights between groups were noted: 
black diabetics (271 ± 17 g), white diabetics (313 ± 18 g), black 
controls (303 ± 19 g), and white controls (291 ± 15 g). How-
ever, when control and diabetic patients with and without 
diabetic nephropathy were grouped according to their serum 
creatinine concentrations, a significant increase in kidney 
weight (P = 0.03) was demonstrated at seram creatinine con-
centrations between 0.5 to 1.5 mg/dL in diabetics with diabetic 
nephropathy (405 ± 32 g) when compared to those without it 
(300 ± 25 g) or to control patients (329 ± 13 g) (Fig 2). In 
patients with seram creatinine concentrations greater than 1.6 
tng/dL, this difference was not apparent (Fig 2). 
The effects of diabetes, race, mean blood pressure, age, and 
sex in the development of renal insufficiency (including end-
stage renal failure) were assessed by logistic regression. The 
logistic regression model demonstrated significant effects only 
for diagnosis (diabetic or control) and race (Table 3). The rela-
tive risk for developing renal insufficiency was increased 36 
'unes if diabetes was present and was fourfold greater in black 
patients. The other variables studied (mean blood pressure, age, 
^d sex) resulted in no added risk. 
100 r 
• Renal Insufficiency 
H End Stage Renal Disease 
DW CB 
Patient Group by Diagnosis and Race 
CW 
Fig I—Prevalence of renal insufficiency (defined as a serum 
creatinine concentration > 2.0 mg/dL) and of end-stage renal 
disease (defined as a serum creatinine > 8.0 mg/dL or need for 
chronic dialysis) in control and type 2 diabetic patients grouped 
by race. (DB = diabetic, black; DW = diabetic, white; CB = 
control, black; CW = control, white.) (P = 0.002 for renal 
insufficiency, and P < 0.05 for end-stage renal disease.) 
• Diabetic («) 
^ Diabetic I-) 
• Contral 
S.Cr. Range 
Fig 2—Kidney weight in grams in control and diabetic patients 
with (-\-) and without ( —) histological evidence of diabetic 
nephropathy when grouped according to serum creatinine con-
centrations (*P = 0.03 when compared to the other groups). 
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Table 3 
Logistic Regression Analysis Data 
Variable Beta* P Value 
Diagnosis 1.028 0.0065 
Race 0.772 0.0317 
Mean blood pressure 0.016 0.1646 
Age -0.03 0.0918 
Sex -0.19 0.6048 
*The estimated regression coefficient for each variable in the model (maximum like-
lihood estimates). 
Discussion 
The puipose of this study was to determine 1) the relationship 
between the presence of diabetic nephropathy and renal insuffi-
ciency, and 2) whether the prevalence of renal insufficiency is 
different in black and white type 2 diabetic patients. A longi-
tudinal prospective study would be ideal in providing data on 
renal function, blood pressure, and blood glucose control, but 
would require a long follow-up period. A cross-sectional design 
could provide adequate data on the prevalence of renal insuffi-
ciency in the study population. However, histological confirma-
tion of diabetic nephropathy would require a substantial number 
of kidney biopsies, even in patients without apparent renal dis-
ease, which poses a serious ethical problem. For these reasons, 
a retrospective cross-sectional autopsy study was chosen. 
As in type 1 diabetes (13), an increase in renal size occurred in 
type 2 diabetic patients with diabetic nephropathy while renal 
function was preserved (Fig 2). The prevalence of histologically 
documented diabetic glomeralosclerosis was 45%, which corre-
lates to previously reported prevalences of 25% to 60% (14-18). 
In addition, the 36% prevalence of renal insufficiency in dia-
betic patients without nephropathy indicates that a significant 
number of patients with type 2 diabetes mellitus have renal dys-
function not related to diabetic renal disease. Hypertensive and 
atherosclerotic renal disease accounted for the majority of renal 
dysfunction in patients without diabetic glomerulosclerosis. 
While the prevalence of renal insufficiency and end-stage renal 
failure (35% and 10%, respectively) in the white population is 
simUar to that in other studies on type 2 diabetes (4,8,14,19-21), 
renal insufficiency and end-stage renal failure were significantly 
more frequent in black than in matched white diabetics (Fig 1) 
and approached that seen in type 1 diabetes (8). Observations 
from the Michigan Kidney Registry also indicate a fourfold in-
crease in the occurrence of end-stage renal failure in black dia-
betics over age 40 when compared to white diabetics, with no 
differences in younger age groups (21). The prevalence of renal 
insufficiency in this study is a minimum estimate, since renal 
insufficiency was arbitrarily defined as a seram creatinine con-
centration greater than 2 mg/dL to ensure that all patients in-
cluded in this category had reduced renal function. 
Age, insulin requirement, and duration of diabetes (Table I) 
do not account for the differences between black and white 
diabetics; however, this study cannot appropriately evaluate 
the possible relevance of the degree of diabetic control (22). 
Nevertheless, mean glucose concentrations during the last hos-
pitalization did not differ between black and white diabetic 
patients or between diabetic patients with and without renal 
insufficiency. 
The possible role of hypertension in the progression of renal 
insufficiency in diabetes has attracted much attention 
(5,6,23-26). In this study, logistic regression analysis didnot 
demonstrate an effect of mean blood pressure, age, or sex on the 
prevalence of renal insufficiency. Although mean blood pressure 
was greater in diabetic patients, only race and the presence or 
absence of diabetes were associated with a significant increased 
risk for renal insufficiency. Several possibilities may account for 
the absence of a blood pressure effect on renal function in this 
study. The severity of hypertension throughout the overal] dura-
tion of diabetes might not have been adequately represented by 
blood pressure measurements during the last hospital admis-
sion. However, cardiac weights were similar, and no differences 
were noted in left ventricular thickness between black and white 
diabetics. Patient selection is another important possibility. 
However, diabetic patients were drawn from an autopsy popula-
tion that included all patients identified as diabetic independent 
of race. In addition, the distribution by race in the population 
studied is similar to the race distribution in Detroit. Finally, 
blacks may have an intrinsic predisposition for developing more 
severe glomerulosclerosis than whites at any given degree of 
hypertension. This difference could be further enhanced by the 
presence of diabetic microvascular disease. The combination of 
diabetes and race would then be a much stronger predictor of 
renal insufficiency than blood pressure alone, as demonstrated 
in this study. Indeed, black hypertensive patients have more se-
vere nephrosclerosis and a lower renal blood flow than whites 
matched for age and degree of hypertension (27,28). In keeping 
with this, black diabetic patients had significantiy more global 
sclerosis than white diabetic or control patients (Table 2), and a 
significant correlation was found between the degree of global 
sclerosis and seram creatinine concentrations. Global sclerosis 
is also commonly observed in patients with focal glomeralar 
sclerosis (29), which is the most characteristic lesion observed 
in heroin nephropathy (30). With equal exposure to nephrotoxic 
factors, the prevalence of end-stage renal failure is also signifi-
cantly greater in black than in white heroin abusers (31). 
A racially determined response pattern of the renal micro-
vasculature to various factors which include diabetes and hyper-
tension may result in more severe global sclerosis and greater 
loss of renal function in black patients with diabetes mellitus in-
dependent of the prevalence of diabetic nephropathy. Further 
prospective studies are required to better define the effects of 
adequate control of diabetes and hypertension on diabetic-
induced renal disease in black and white patients. The implica-
tion that end-stage renal failure occurs more frequentiy in 
black type 2 diabetic may be relevant in the planning of end-
stage renal failure treatment programs. 
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